1634. Respiratory Syncytial Virus-Associated Health Care Utilization in the Pivotal Phase 3 Trial RSV Vaccine Efficacy Study In Older Adults Immunized Against RSV Disease (RENOIR)

BACKGROUND: Respiratory Syncytial Virus (RSV)-related disease poses an economic burden due to a substantial amount of health care utilization (HCU). RENOIR is a phase 3 global, multicenter, randomized, double-blinded, placebo-controlled study evaluating vaccine efficacy (VE) in adults ≥60 years of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Edward E, Ilangovan, Kumar, Zareba, Agnieszka, Jiang, Qin, Marc, Gonzalo Pérez, Verbeek, Tjitte, Breedt, Johannes, Stacey, Helen, Uchiyama, Akiyoshi, Ojanperä, Jussi, DeHaan, Elliot N, Patton, Michael, Kan, Yanqing, Eiras, Daniel P, Mikati, Tarek, Kalinina, Elena, Cooper, David, Anderson, Annaliesa S, Swanson, Kena A, Gruber, William C, Gurtman, Alejandra C, Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677386/
http://dx.doi.org/10.1093/ofid/ofad500.1468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677386/
http://dx.doi.org/10.1093/ofid/ofad500.1468

Ejemplares similares